Beta blockers and anesthesia

Slides:



Advertisements
Similar presentations
Beta Blockers In Anesthesia. Introduction Introduction.
Advertisements

Jara – Medrano (“Jarano”). * Indications: acute bronchospasm, severe bronchospasm, acute severe asthma * Pharmacokinetics: * Route: Inhaled, oral * Absorption:
Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 )
B) Drug Therapy (Antihypertensives) ACEi B.B CCB D iuretics. Centrally acting agents: alphametyldopa, HTN + pregnancy.
Pharmacology II The Autonomic Nervous System Adrenergic antagonists
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 45 Calcium Channel Blockers.
Beta-Adrenergic Blockers  Types of adrenoceptors Alpha-1  Vasoconstriction  Increased peripheral resistance  Increased blood pressure Alpha-2  Inhibition.
ALPHA BLOCKERS Alpha receptors have been further subdivided into alpha1 and alpha2 receptors. Alpha -1 receptors – Upon stimulation, leads to increased.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 18 Adrenergic Antagonists.
Adrenergic Blockers Asmah Nasser, M.D..
Beta Blockade and the Heart John Hakim, M.D Cardiology Fellow West Virginia University Division of Cardiology.
Chapter 18 Agents that Dilate Blood Vessels. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Coronary.
Adrenoceptor Blockers
ADRENERGIC ANTAGONITS
Compact CNS α 2 Vagus Nerve I-1 Preload Afterload α 1 Renin Baroreflex
EMS 353. Lectures 6 Dr. Maha Khalid physiology of pharmacology cardiovascular system.
Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab.DCA, Dip. Software statistics- Ph d Mahatma Gandhi Medical college and research institute, puducherry,
Chapter 17 Cardiac Stimulants and Depressants. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved
 Hypertension : BPDIASTOLIC SYSTOLIC Normal< 130< 85 Mild hypertension Moderate hypertension Severe Hypertension 180.
Adrenergic antagonist sympatholytic
Adrenergic Antagonist (Sympatholytics)
Table 1. Biological Responses Mediated by Adrenergic Receptors in the Human Heart Biological ResponseAdrenergic Receptor Mediation Cardiac myocyte growthß.
Good Morning 20 August Anesthetic Considerations in Patients With Cardiac Arrhythmias 麻醉科 林子富.
Agents that Dilate Coronary Blood Vessels.  Coronary artery disease (CAD) results from atherosclerosis  Clinical symptoms caused by  narrowing of the.
HuBio 543 September 27, 2007 Neil M. Nathanson K-536A, HSB
for more lecture notes Antianginal Agents Dr.Shadi-Sarahroodi Pharm.D & PhD Qom University of Medical sciences Iran PUBLISHED.
Adrenergic Receptor Antagonists Excessive sympathetic activity is characteristic of a number of pathological states including: Hypertension Angina pectoris.
Alpha & beta- adrenergic receptor blockers Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics  Form False Transmitters  Deplete.
BETA ADRENOCEPTOR BLOCKERS. OCH 2 CH CH 2 NHCH CH 3 OH CH 2 CH CH 2 NHCH OH CH 3 CH 3 OCHCH 2 PROPRANOLOL METOPROLOL.
Adrenergic Antagonists (Sympatholytics)
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
Adrenergic Antagonists
 - Adrenoceptors blockers Prof. Hanan Hagar Pharmacology Unit College of Medicine.
SYMPATHOLYTIC AGENTS Beta Receptor Blockers. BETA-ADRENERGIC RECEPTOR BLOCKERS  Widely used clinically for a variety of conditions ; mainly CVS  Dichloro-isoproterenol.
PHARMACOLOGY OFADRENERGICS
Adrenergic Receptor Antagonists These are drugs which antagonize α or β or both α and β adrenergic receptors Adrenergic neurone blocking agents (Sympatholytic)
-ADRENOCEPTOR ANTAGONISTS
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.1 Drugs for Angina Pectoris.
1 ADRENERGIC ANTAGONITS. 2 ADRENERGIC BLOCKERS ALPHA BLOCKERS Alpha 1 Blockers Nonselective Alpha Blockers Doxazosin Phenoxybenzamine Prazosin Phentolamine.
Adrenergic Antagonists
Alpha & beta- adrenergic receptor blockers Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics  Form False Transmitters  Deplete.
Investigation of the effects of ß-blockers on CVS
CODE BLUE MANAGEMENT DRUG THERAPY
PHARMACOLOGY OFADRENERGICS
Calcium Channel Blocking Drugs.
Sympatholytic & adrenergic blockers -receptor Antagonists
β-adrenergic antagonists
- Adrenoceptors blockers
MD., DA., DNB, MD (Acu), Dip. Diab. DCA, Dip. Software statistics,
Anti-Anginal Drugs.
Traditional parenteral antihypertensive treatment
β – ADRENERGIC BLOCKERS
Anti-Anginal Drugs.
ANTI HYPERTENSIVE DRUGS
ANTI HYPERTENSIVE DRUGS
Beta-adrenergic blocking agents
Dr. PJ Devereaux on behalf of POISE Investigators
Antianginal Drugs.
Effect of β-adrenergic Blockers on the Arterial Blood Pressure
Anti hypertensive Drugs
Drugs Acting on the Heart
Antiarrhythmic Drugs Types of Cardiac Arrhythmias:
- Adrenoceptors blockers
Adrenergic Antagonists
Recent advances – levosimendan
Drugs used in the treatment of arrhythmia I
Chaper 20 Adrenoceptor Antagonists
BETABLOCKERS THIRUMURUGAN E MSC CVT. SYMPATHETIC NERVOUS SYSTEM  FIGHT  FEAR  FLIGHT.
Presentation transcript:

Beta blockers and anesthesia Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab. DCA, Dip. Software statistics PhD ( physiology) – IDRA, FICA

Mainly non cardiac surgeries

What are they ? Preferentially blocks beta receptors of the adrenergic system

Classify ? Nonselective blockers. – With ISA (Intrinsic sympathetic activity): Pindolol. – With MSE (Membrane stabilising effect): Propranolol, sotolol, timolol. – Both ISA and MSE: Alprenolol, oxyprenolol. – Neither ISA or MSE: Nadolol. • Cardioselective blockers. – With ISA: Practolol, acebutolol – With MSE: Acebutolol – Neither ISA or MSE: Atenolol, metoprolol, esmolol Pro – BBB cross Aten – no

Actions !! Reduce heart rate Reduce contractility - reduce cardiac output Decrease AV nodal conduction Decrease arrythmogenicity - phase IV decrease Reduced rennin angiotensin activity Peripheral vasoconstriction Bronchospasm Decreased glucagon response to hypoglycemia Decrease IOP ISA activity ?

Carvidolol-- some vasodilation Nebivolol nitric oxide potentiation

Indications Hypertension Angina Sinus tachycardia and paroxysmal atrial tachycardia Coronary artery disease Dissection aorta Hypertrophic obstructive cardiomyopathy QT–prolongation syndrome Cyanotic spells in tetralogy of Fallot.

Other indications Prophylaxis of migraine Essential tremor Anxiety Alcohol withdrawal syndrome. Thyrotoxicosis Glaucoma

Contraindications to beta blockers Peripheral arterial disease AV blocks Bronchospasm Frank CCF ! -- Slow start and slow rise Bradycardia and hypotension and hypoglycemia in fetus – beware

Anesthetic beta blocker Esmolol is effective in quick control of supraventricular tachyarrhythmias in patients with acute myocardial infarction where it reduces heart rate and myocardial oxygen demand. It is also used to control perioperative hypertension with tachycardia. Dose of esmolol 50 to 200 mcg/kg/min. rapid onset (within 20 seconds) short duration of action (9 to 10 min). 10 mg / ml – 10 ml vial

Acts better when sympathetic activity is high !!

When its working ? Heart rate around 55 Less than 20 % increase with stress Should not be any AV block Then its working

They don’t do !! Beta-blockers do not affect the serum electrolytes, particularly serum potassium/serum uric acid levels, but glucose tolerance deteriorates in some non-insulin dependent diabetics also .

Anesthetic considerations

Premedication Already on drugs continue Think of using in hypotensive anesthesia

Anesthetic considerations volatile agents produce more CVS depression

Bradycardia may be more severe In general anesthesia Fentanyl Vecuronium Neostigmine Succinyl choline Bradycardia may be more severe

General anesthesia – concerns . Normal sympathetic response to blood loss, acute hypovolaemia may be obtunded: Simultaneous use of calcium channel blockers cause additive myocardial depression Bradycardia following acute blood loss should be anticipated. Avoid Hypercarbia should be avoided - hypotension because the vasodilatation produced by carbon dioxide is no longer offset by tachycardia due to activation of the adrenergic system

Can we reverse ?? Atropine–dose - 2 to 3 mg intravenously. Isoprenaline–specific antagonist for beta adrenergic blocking drugs. It is given as an infusion with a dose of 2 to 5 mcg/min Calcium chloride–increases myocardial contractility. Dose: 500 to 100 mg over 10 to 20 min. Aminophylline–5 mg/kg/IV, inhibits phosphodiesterase, Glucagon 5-10 mg I/V Cardiac pacing.

Other uses To abolish hypertensive response to laryngoscopy. Adjunct to nitroprusside induced hypotension. Postoperative hypertension in coronary artery bypass graft patients. For by pass surgery on beating heart. Supraventricular arrhythmias.

In neuraxial anesthesia Heart rate fall and hypotension more Test dose may not be foolproof Other causes of tachycardia ruled out – think of beta blockers Ephedrine – unopposed alpha activity

POISE (Peri Operative ISchemic Evaluation) showed the benefit of a perioperative β blockade in terms of reduction in cardiovascular death and MI, but with an increased risk of stroke and total mortality. 1 week prior to surgery – important Postop continue

Summary What drugs Classification Effects Uses Contraindications General anesthesia Regional POISE trial